Fighting drug resistance on Asia's malaria frontline

November 4, 2012 by Daniel Rook

At a remote medical outpost near the jungle-blanketed Thai-Myanmar border, a villager pricks the finger of a feverish baby living on the frontline of the war on drug-resistant malaria.

The tiny walk-in clinic—and hundreds more like it scattered along Thailand's porous frontiers—are a key part of efforts to stop the spread of the lethal new strain from Southeast Asia to the Indian subcontinent and Africa.

For more than a decade, the fast-acting treatment has been Thailand's most potent weapon in the long-running battle against , contributing to a sharp drop in the number of deaths.

It is the most commonly used drug worldwide against a that infects 216 million people and claims 655,000 lives around the globe each year.

But after artemisinin-defying parasites emerged on the Thai-Cambodian border about eight years ago—and were later discovered in western Thailand, Myanmar and Vietnam—fears are growing that the wonder drug is losing its potency.

And so far there is no other treatment that packs the same punch.

"If the resistance spreads there will be a surge in cases," warned Fatoumata Nafo-Traore, director of the Partnership, which coordinates the global fight against the disease.

At a meeting in Sydney last week, leading scientists and health experts flagged the need for tougher political leadership and regional coordination in Asia to combat malaria, with the drug-resistant strain a particular worry.

For people living in the Thai-Myanmar border villages, malaria is a daily risk.

"When people in this area start shivering and become ill, they hurry here," said Laksanara Kaewlere, a former rice farmer who runs one of the outposts in western Kanchanaburi province.

In the local subdistrict, of about 190 cases of malaria in the past year, 40 people still had the parasite one month after initial treatment—double the number in the previous year, said disease control official Wittaya Saiphomsud.

"In the past, when we gave patients the drugs they recovered completely in three days. But now when they take them, they have malaria again within less than a month," he said.

The authorities have begun monitoring patients taking their daily doses to ensure they complete the prescribed regimen in order to completely kill the parasite and reduce the risk of drug resistance.

Sales of counterfeit or poor-quality medicine without enough quantity of the active ingredient are also part of the problem.

On the other side of the border in Win Kan village in Myanmar's Mon State, volunteer Than Nwet tests patients for malaria and distributes medicine provided by the Christian humanitarian organisation World Concern.

In the past, most villagers bought drugs from local shops, she told AFP.

"They took medicine without a doctor's prescription so the malaria became resistant to the drugs. About one-third of people still buy medicine from a nearby shop," she said.

— Fears of a surge in cases —

Nobody knows for sure if artemisinin- was spread by migrant workers or developed independently in areas hundreds of kilometres (miles) apart.

For now the drug remains effective in most cases, and second-line treatments—albeit less potent—ensure deaths are still relatively rare in Thailand, which reported about 30,000 cases and 12 fatalities in 2011.

But experts fear that if the resistance becomes more prevalent, and creeps further westwards, years of progress will unravel.

Billions of dollars of investment and a decade of progress "will probably be hijacked" if the resistance spreads to malaria-ridden Africa, said World Health Organisation regional expert Charles Delacollette.

While Thai campaigns to encourage people to sleep under mosquito nets have helped reduce infection rates, not everybody heeds the advice.

Sitting in his home in Kanchanaburi province as he recovers from a bout of malaria, villager Chong said he is afflicted with the disease every year, and lost his son to the illness several decades ago.

"Every month I go to the forest," said the 57-year-old, who goes by one name, admitting that he does not use a sleeping net when he ventures across the border to cut bamboo shoots.

Decades of military rule and ethnic conflicts have left Myanmar's health system in tatters, and malaria is endemic in much of the country.

The government reported about 420,000 confirmed cases and 788 deaths in 2010, but that is believed to be a small fraction of the actual total.

Drug-resistant cases are estimated to account for about 15 percent of the total in certain areas, according to Saw Lwin, deputy director general of Myanmar's health ministry.

As the country now opens up after decades of isolation, increased migration flows pose a new challenge.

When previous generations of medicines lost their efficacy, infections spiked and resistance rippled out from the region through Myanmar and eventually to Africa, which sees 90 percent of worldwide malaria deaths.

"Our country is the gateway for the spread of drug-resistant parasites westwards and to Africa," Saw Lwin warned.

Experts say time may be running out to prevent history repeating itself.

Explore further: WHO hopeful drug-resistant malaria can be contained

Related Stories

WHO hopeful drug-resistant malaria can be contained

April 24, 2012
The World Health Organisation said Tuesday it was optimistic drug-resistant malaria that has emerged along Thailand's borders with Cambodia and Myanmar could be contained within the region.

WHO urges action as drug-resistant malaria spreads

September 27, 2012
The World Health Organization said Thursday that governments in the Mekong region must act "urgently" to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar.

Asia battles drug-resistant malaria

October 31, 2012
Drug-resistant malaria is spreading in Asia, experts warned as a high-level conference opened Wednesday with the aim of hammering out an action plan to strengthen the region's response.

New fight needed against killer malaria in Asia

November 2, 2012
Asia is hit with 30 million cases of malaria a year resulting in 42,000 deaths, a report said Friday as experts called for an urgent response to the disease which stalks billions in the region.

Study finds early signs of malaria drug resistance in Africa

April 27, 2012
Africa's deadliest malaria parasite has shown resistance in lab tests to one of the most powerful drugs on the market -- a warning of possible resistance to follow in patients, scientists said Friday.

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.